{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T22:13:16Z","timestamp":1788473596423,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004681","name":"Higher Education Commission, Pakistan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004681","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.compbiomed.2026.111506","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T11:34:50Z","timestamp":1770032090000},"page":"111506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Exploring natural products as Bcl-2 inhibitors for acute myeloid leukemia therapy using In vitro, STD-NMR spectroscopy, and In silico approaches"],"prefix":"10.1016","volume":"204","author":[{"given":"Noor","family":"Rahman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humaira","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thirugnanasambandam","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruby","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Almehdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atia","family":"tul-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumbla","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Iqbal","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2026.111506_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122181","article-title":"Drug repurposing for the identification of new Bcl-2 inhibitors: in vitro, STD-NMR, molecular docking, and dynamic simulation studies","author":"Rahman","year":"2023","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrm2308","article-title":"The BCL-2 protein family: opposing activities that mediate cell death","volume":"9","author":"Youle","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111506_bib3","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41419-019-1407-6","article-title":"BCL-2 family isoforms in apoptosis and cancer","volume":"10","author":"Warren","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/cdd.2017.183","article-title":"Why do BCL-2 inhibitors work and where should we use them in the clinic?","volume":"25","author":"Montero","year":"2018","journal-title":"Cell Death Differ."},{"issue":"5137","key":"10.1016\/j.compbiomed.2026.111506_bib5","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1126\/science.8235659","article-title":"Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species","volume":"262","author":"Kane","year":"1993","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.compbiomed.2026.111506_bib6","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1002\/jcp.28091","article-title":"The Bcl\u20102 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML","volume":"234","author":"Nguyen","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.compbiomed.2026.111506_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjc.2015.85","article-title":"Mitochondrial apoptosis: killing cancer using the enemy within","volume":"112","author":"Lopez","year":"2015","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.compbiomed.2026.111506_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104264","article-title":"Drug-like biimidazole derivatives dually target c-MYC\/BCL-2 G-quadruplexes and inhibit acute myeloid leukemia","volume":"104","author":"Hu","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111506_bib9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1582-4934.2003.tb00225.x","article-title":"Regulation of apoptosis by Bcl\u20102 family proteins","volume":"7","author":"Burlacu","year":"2003","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.compbiomed.2026.111506_bib10","series-title":"The Battle Against ALK Resistance: Successes and Setbacks","first-page":"1751","author":"Voena","year":"2012"},{"issue":"50","key":"10.1016\/j.compbiomed.2026.111506_bib11","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1038\/onc.2008.307","article-title":"Bcl-2 family proteins and cancer","volume":"27","author":"Yip","year":"2008","journal-title":"Oncogene"},{"issue":"21","key":"10.1016\/j.compbiomed.2026.111506_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111315","article-title":"Bcl-2 modulation in p53 signaling pathway by flavonoids: a potential strategy towards the treatment of cancer","volume":"22","author":"Rahman","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-015-0224-3","article-title":"ABT-199 (venetoclax) and BCL-2 inhibitors in clinical development","volume":"8","author":"Cang","year":"2015","journal-title":"J. Hematol. Oncol."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib14","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.bmcl.2008.10.113","article-title":"Tetrahydroisoquinoline amide substituted phenyl pyrazoles as selective Bcl-2 inhibitors","volume":"19","author":"Porter","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cbic.200600305","article-title":"Novel Bcl\u20102 inhibitors: discovery and mechanism study of small organic apoptosis\u2010inducing agents","volume":"8","author":"Zhang","year":"2007","journal-title":"Chembiochem"},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jcp.21567","article-title":"Non\u2010peptidic small molecule inhibitors against Bcl\u20102 for cancer therapy","volume":"218","author":"Azmi","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"sup1","key":"10.1016\/j.compbiomed.2026.111506_bib17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1076\/phbi.39.s1.8.0009","article-title":"Natural product drug discovery in the next millennium","volume":"39","author":"Cragg","year":"2001","journal-title":"Pharm. Biol."},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111506_bib18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","article-title":"Natural products as sources of new drugs from 1981 to 2014","volume":"79","author":"Newman","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"5","key":"10.1016\/j.compbiomed.2026.111506_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.lfs.2005.09.012","article-title":"Drug discovery from medicinal plants","volume":"78","author":"Balunas","year":"2005","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.compbiomed.2026.111506_bib20","first-page":"35","article-title":"Anti-cancer agents from medicinal plants","volume":"1","author":"Shoeb","year":"2006","journal-title":"Bangladesh J. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111506_bib21","first-page":"115","article-title":"Visual experiment MTT assay to evaluate the cytotoxicity potential of a drug, Bangladesh J","volume":"12","author":"Khan","year":"2017","journal-title":"Pharmacol"},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s43088-020-00059-7","article-title":"In silico molecular docking studies and MM\/GBSA analysis of coumarin-carbonodithioate hybrid derivatives divulge the anticancer potential against breast cancer","volume":"9","author":"Pattar","year":"2020","journal-title":"Beni-Suef University Journal of Basic and Applied Sciences"},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib23","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41423-023-01112-y","article-title":"The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting a favorable response to anti-PD-1 therapy via NLRP3 activation","volume":"21","author":"Luo","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.compbiomed.2026.111506_bib24","first-page":"1081","article-title":"Targeting BCL-2 in B-cell lymphomas","volume":"130","author":"Davids","year":"2017","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"5","key":"10.1016\/j.compbiomed.2026.111506_bib25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/sj.bjc.6605736","article-title":"BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received","volume":"103","author":"Dawson","year":"2010","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.compbiomed.2026.111506_bib26","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41419-021-03500-6","article-title":"The application of BH3 mimetics in myeloid leukemias","volume":"12","author":"Parry","year":"2021","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.compbiomed.2026.111506_bib27","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.canlet.2010.09.012","article-title":"Targeting apoptosis pathways in lung cancer","volume":"332","author":"Pore","year":"2013","journal-title":"Cancer letters"},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"issue":"13","key":"10.1016\/j.compbiomed.2026.111506_bib29","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1073\/pnas.97.13.7124","article-title":"Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells","volume":"97","author":"Wang","year":"2000","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.compbiomed.2026.111506_bib30","doi-asserted-by":"crossref","first-page":"697","DOI":"10.3389\/fphar.2019.00697","article-title":"Efficacy and safety of Bcl-2 inhibitor venetoclax in hematological malignancy: a systematic review and meta-analysis of clinical trials","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.compbiomed.2026.111506_bib31","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1517\/13543784.14.11.1419","article-title":"Investigations on gossypol: past and present developments","volume":"14","author":"Dodou","year":"2005","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"1\u20133","key":"10.1016\/j.compbiomed.2026.111506_bib32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.theochem.2005.05.010","article-title":"Conformational analysis of gossypol and its derivatives by molecular mechanics","volume":"730","author":"Beisel","year":"2005","journal-title":"J. Mol. Struct.: THEOCHEM"},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0006-2952(03)00248-X","article-title":"Molecular mechanism of gossypol-induced cell growth inhibition and cell death of HT-29 human colon carcinoma cells","volume":"66","author":"Zhang","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111506_bib34","article-title":"Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer","author":"Passos","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.compbiomed.2026.111506_bib35","series-title":"Preparation of Phytopharmaceuticals for the Management of Disorders","first-page":"409","article-title":"Conservation and sustainable use of medicinal plants","author":"Gusain","year":"2021"},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111506_bib36","first-page":"649","article-title":"Bcl-2 gene prevents induction of apoptosis in l1210 murine leukemia-cells by sn-38, a metabolite of the camptothecin derivative cpt-11","volume":"4","author":"Kondo","year":"1994","journal-title":"Int. J. Oncol."},{"issue":"7","key":"10.1016\/j.compbiomed.2026.111506_bib37","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0305-1978(98)00124-0","article-title":"Jaceidin and chrysosplenetin chemotypes of Chamomilla recutita (L.) Rauschert","volume":"27","author":"Rep\u010d\u00e1k","year":"1999","journal-title":"Biochem. Systemat. Ecol."},{"key":"10.1016\/j.compbiomed.2026.111506_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/BF02146923","article-title":"The synthesis of jaceidin","volume":"24","author":"Fukui","year":"1968","journal-title":"Experientia"},{"issue":"3","key":"10.1016\/j.compbiomed.2026.111506_bib39","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0008-6363(99)00384-3","article-title":"Morphologic and biochemical hallmarks of apoptosis","volume":"45","author":"Saraste","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2026.111506_bib40","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1186\/s12967-024-05647-0","article-title":"NL101 synergizes with the BCL-2 inhibitor venetoclax through PI3K-dependent suppression of c-Myc in acute myeloid leukaemia","volume":"22","author":"Lu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.compbiomed.2026.111506_bib41","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0026-895X(25)13034-4","article-title":"Antiproliferative and cytotoxic effects of newly discovered halogenated coral prostanoids from the Japanese stolonifer Clavularia viridis on human myeloid leukemia cells in culture","volume":"32","author":"Honda","year":"1987","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111506_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.796300","article-title":"Apoptosis triggering, an important way for natural products from herbal medicines to treat pancreatic cancers","volume":"12","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111506_bib43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1054-3589(08)61069-8","article-title":"Chemotherapy-induced apoptosis","volume":"41","author":"Mesner","year":"1997","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.compbiomed.2026.111506_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0378-4274(99)00252-0","article-title":"Activation of apoptosis pathways by anticancer treatment","volume":"112","author":"Debatin","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.compbiomed.2026.111506_bib45","series-title":"Anticarbohydrate Antibodies: from Molecular Basis to Clinical Application","first-page":"385","article-title":"The interaction of saccharides with antibodies. a 3D view by using NMR","author":"Marcelo","year":"2011"},{"issue":"4","key":"10.1016\/j.compbiomed.2026.111506_bib46","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1039\/C2MB25395J","article-title":"Recent developments and applications of saturation transfer difference nuclear magnetic resonance (STD NMR) spectroscopy","volume":"9","author":"Wagstaff","year":"2013","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.compbiomed.2026.111506_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jmgm.2017.11.011","article-title":"Exploring the selectivity of inhibitor complexes with Bcl-2 and Bcl-XL: a molecular dynamics simulation approach","volume":"79","author":"Wakui","year":"2018","journal-title":"J. Mol. Graph. Model."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482526000673?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482526000673?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T13:03:52Z","timestamp":1775480632000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482526000673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":47,"alternative-id":["S0010482526000673"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111506","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring natural products as Bcl-2 inhibitors for acute myeloid leukemia therapy using In vitro, STD-NMR spectroscopy, and In silico approaches","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2026.111506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"111506"}}